EPISODE · Jun 19, 2026 · 9 MIN
FDA: Moderna mRNA Vaccine Against Seasonal Influenza 27% More Effective
Il comitato consultivo della FDA ha votato all'unanimitàa favore dell'approvazione del vaccino stagionale contro l'influenza mRNA-1010 di Moderna, noto come mFlusiva. I dati di Fase 3 mostrano un'efficacia superiore del 27% rispetto ai vaccini tradizionali e una risposta immunitaria più forte negli over 65. La tecnologia mRNA promette anche una risposta rapida a nuove varianti.
Embed this episode
NOW PLAYING
FDA: Moderna mRNA Vaccine Against Seasonal Influenza 27% More Effective
0:00
9:10
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of GoYou Technology (EN)?
This episode is 9 minutes long.
When was this GoYou Technology (EN) episode published?
This episode was published on June 19, 2026.
Can I download this GoYou Technology (EN) episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!